Evidence map›Paper›PMID 26258652›Full record

ArticlePloS one2015

Tlx3 promotes glutamatergic neuronal subtype specification through direct interactions with the chromatin modifier CBP.

Atsushi Shimomura, Dharmeshkumar Patel, Sarah M Wilson, Karl R Koehler, Rajesh Khanna, Eri Hashino

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Deciphering precursor cell dynamics in esophageal preneoplasia via genetic barcoding and single-cell transcriptomics.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Atsushi ShimomuraStark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, United States of America; Department of Otolaryngology-Head and Neck Surgery, Indiana University School of Medicine, Indianapolis, Indiana, United States of America; School of Psychological Science, Health Sciences University of Hokkaido, Sapporo, Hokkaido, Japan.
Dharmeshkumar PatelStark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, United States of America; Department of Otolaryngology-Head and Neck Surgery, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
Sarah M WilsonStark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, United States of America; Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
Karl R KoehlerStark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, United States of America; Department of Otolaryngology-Head and Neck Surgery, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
Rajesh KhannaStark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, United States of America; Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America; Department of Pharmacology, University of Arizona School of Medicine, Tucson, Arizona, United States of America.
Eri HashinoStark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, Indiana, United States of America; Department of Otolaryngology-Head and Neck Surgery, Indiana University School of Medicine, Indianapolis, Indiana, United States of America; Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
Indiana University – Purdue University Indianapolis · USHealth Sciences University of Hokkaido · JPIndiana University School of MedicineUniversity of Arizona · US

Funding

Modeling Inner Ear Differentiation with Pluripotent Stem CellsR01DC013294 · NIDCD · INDIANA UNIVERSITY INDIANAPOLIS · PI Eri Hashino · 2014 to 2026
$7.1M
NIDCD NIH HHS R01 DC013294NIDCD NIH HHS R01DC013294
6 · The paper itself

Abstract

Nervous system development relies on the generation of precise numbers of excitatory and inhibitory neurons. The homeodomain transcription factor, T-cell leukemia 3 (Tlx3), functions as the master neuronal fate regulator by instructively promoting the specification of glutamatergic excitatory neurons and suppressing the specification of gamma-aminobutyric acid (GABAergic) neurons. However, how Tlx3 promotes glutamatergic neuronal subtype specification is poorly understood. In this study, we found that Tlx3 directly interacts with the epigenetic co-activator cyclic adenosine monophosphate (cAMP)-response element-binding protein (CREB)-binding protein (CBP) and that the Tlx3 homeodomain is essential for this interaction. The interaction between Tlx3 and CBP was enhanced by the three amino acid loop extension (TALE)-class homeodomain transcription factor, pre-B-cell leukemia transcription factor 3 (Pbx3). Using mouse embryonic stem (ES) cells stably expressing Tlx3, we found that the interaction between Tlx3 and CBP became detectable only after these Tlx3-expressing ES cells were committed to a neural lineage, which coincided with increased Pbx3 expression during neural differentiation from ES cells. Forced expression of mutated Tlx3 lacking the homeodomain in ES cells undergoing neural differentiation resulted in significantly reduced expression of glutamatergic neuronal subtype markers, but had little effect on the expression on pan neural markers. Collectively, our results strongly suggest that functional interplay between Tlx3 and CBP plays a critical role in neuronal subtype specification, providing novel insights into the epigenetic regulatory mechanism that modulates the transcriptional efficacy of a selective set of neuronal subtype-specific genes during differentiation.

Indexed as

Gene Expression Regulation, DevelopmentalAnimalsCell DifferentiationCell LineageChromatinCREB-Binding ProteinEmbryo, MammalianEmbryonic Stem CellsEpigenesis, GeneticFluorescent DyesFura-2GABAergic NeuronsGlutamic AcidHEK293 CellsHomeodomain ProteinsHumansChromatinCREB-Binding ProteinCrebbp protein, mouseFluorescent DyesFura-2Glutamic AcidHomeodomain Proteinsproto-oncogene protein Pbx3Proto-Oncogene ProteinsRepressor ProteinsTgif1 protein, mouseTlx3 protein, mouse

Identifiers

PMID26258652
PMCPMC4530954
OpenAlexW1957166790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.